GRIN2B and neurodegenerative disease: Extrasynaptic GluN2B-containing N-methyl-d-aspartate (NMDA) receptors have been implicated in neurodegenerative diseases, such as Alzheimer’s and Huntington’s disease via the activation of proapoptotic signaling cascades (Hardingham and Bading 2010; Li et al. 2011).